CereCRIB implant: Began safety study in Switzerland

CytoTherapeutics Inc. (CTII) Product: CereCRIB implant. Cells inside the device produce catecholamines and enkephalins, morphine-like substances Indication: Severely ill patients in chronic pain Statu...